Login to Your Account



Cellartis, Novo, Lund University in $125M Diabetes Stem Cell Pact

By Cormac Sheridan


Wednesday, October 29, 2008
Stem cell science specialist Cellartis AB could earn as much as €100 million (US$125 million) in development and sales milestones from a cell therapy collaboration in diabetes with Novo Nordisk A/S and Lund University in Sweden. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription